Robert J. Hombach

Director

Robert J. Hombach (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Embecta Corp. (EMBC). Across 2 priced purchase filings, the average 21-session return was +7.5% from execution and +8.3% from disclosure (delay-adjusted; derived). The largest single filing was $236K of SPTX (13,000 sh × $18.14, as filed), executed Jun 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+7.5%

avg across 2 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+8.3%

same 2 filings, from disclosure

Filings, ttm

2 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$460K

shares × price, as filed

Last traded

Aug 12

Filed Aug 13

Median ADV $8.4M across their filed names

Open performance→

Volume by month

Buys $460K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

EMBC

Embecta Corp. EMBC · 1 buy · 0 sells 1 filing SPTX Seaport Therapeutics, Inc. SPTX · 1 buy · 0 sells 1 filing

Recent filings

EMBCPURCHASE Embecta Corp. View filing → $224K
45,000 sh × $4.97
Exec Aug 12
Filed Aug 13 · 10:45 AM ET SPTXPURCHASE Seaport Therapeutics, Inc. View filing → $236K
13,000 sh × $18.14
Exec Jun 22
Filed Jun 24 · 6:05 AM ET